|
524636 OXYGENTAPH Group (X) 22 Apr,15:27
57.00
-0.45 (-0.78%)
HOW HOT IS THIS STOCK?
Last 15 days data © Rediff.com Add to Watchlist
|
BSE | NSE
 ZoomRefreshDay
Wk
Mn
6Mn
Yr
|
1 min read
15 minutes ago
2 min read
16 minutes ago
2 min read
37 minutes ago
1 min read
40 minutes ago
| Mar ' 25 | Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | |
|---|---|---|---|---|---|
| Sales | 109.30 | 39.64 | 30.99 | 60.52 | 52.03 |
| Operating profit | -9.99 | -9.70 | -7.12 | 1.48 | 3.84 |
| Interest | 3.61 | 1.59 | 1.49 | 0.92 | 1.78 |
| Gross profit | -12.30 | -11.25 | -8.59 | 0.56 | 2.15 |
| EPS (Rs) | -2.78 | -1.04 | -8.15 | -0.43 | 2.87 |
1 min read
5 minutes ago
1 min read
10 minutes ago
Q: What is the current share price of Oxygenta Pharmaceutical Ltd.?
A: The current share price of Oxygenta Pharmaceutical Ltd. is ₹ 57.00 (for BSE as on 22 Apr,15:27). The 52-week range is ₹ 133.50 - 45.30. Prices are updated based on live market data.
Q: What is the market capitalization of Oxygenta Pharmaceutical Ltd.?
A: Oxygenta Pharmaceutical Ltd. has a market capitalization of ₹ 210.91 Cr, making it a company.
Q: What is the PE ratio of Oxygenta Pharmaceutical Ltd.?
A: The Price-to-Earnings (PE) ratio of Oxygenta Pharmaceutical Ltd. is -20.83, indicating its valuation relative to earnings.
Q: Is Oxygenta Pharmaceutical Ltd. a good investment?
A: Oxygenta Pharmaceutical Ltd. is considered based on its financial performance, sector outlook, and market conditions. Investors should evaluate fundamentals and consult financial advisors before investing.
Q: What are the latest financial results of Oxygenta Pharmaceutical Ltd.?
A: Oxygenta Pharmaceutical Ltd. has reported its latest annual results with revenue of ₹ 109.30 and net profit/loss of ₹ -10.30.
© 2026 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
.jpg)
